SEO URLwww.firestrike.ai/deals/nanotess-embecta-acquisition-2026
acquisitionAnnounced · Mar 10, 2026Health CareSource · CredibleArticle · Factual
Embecta acquires NanoTess
David Najork · Founding Software Engineer
Published · Updated · 1 min read
Deal value
—
Target
NanoTess
Calgary, Alberta
Acquirer
Embecta
Financial Stake
Status
Announced
Embecta agreed to acquire NanoTess. Reported deal value: Undisclosed. Status: Announced. Sector: Health Care. Target headquarters context: Calgary, Alberta, Canada.
This page summarizes publicly available information about the transaction as of 2026-03-10. Figures and status may change as filings and press coverage update.
, March 10, 2026 /CNW/ – Calgary startup NanoTess , an innovator in catalytic skin and wound care solutions, has signed a distribution agreement with embecta , the world leading producer of insulin injection devices, to distribute NanoSALV Catalytic to 14,000+ pharmacies across Canada
Deal timeline
Announced
Mar 10, 2026 · cantechletter.com
Additional milestones (proxy, vote, close) appear as filings and press updates are indexed.
Sector context
This transaction is classified in Health Care. Figures and status may change as sources update.
Sources: cantechletter.com · Primary article · FireStrike proprietary index